Send feedback

A2M p.Ser357Pro

c.1069T>C · VCV3417232

Likely benign Single submitter
Classification
Likely benign
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely benign
0.0764 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 8.48e-05%, nfe)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt

Computational evidence

Protein change
AlphaMissense0.0764likely benign
REVEL0.018moderately benign-leaning
SaProtLLR -5.39tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 0.47GERP 0.43, phastCons 0.29
Regional constrainto/e 0.84unconstrained · MANE · 48 kb · p 4.5e-12 · regional, not allelic
Overall
CADD7.849PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 8.48e-05% European (non-Finnish) · 1/1,178,588 alleles
Overall 6.85e-05% 1/1,460,196 alleles · very rare

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
A2M
Protein
p.Ser357Pro
Coding
c.1069T>C
MANE Select
NM_000014
Type
single nucleotide variant
Location
chr12:9106271 (GRCh38)
Gene constraint
LOEUF 0.765 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 81.61 · 13 PDB
Full A2M gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/a2m-p-ser357pro (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown